Approval · Notice of Compliance 17364 · 2015
COPAXONE: Notice of Compliance 17364
Issued October 2, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17364
- Date
- October 2, 2015
- Company
- Teva Pharmaceutical Industries LtdPetach Tikva, --, Israel
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update and creation of the patient medication information according to the plain language labelling
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | Not yet assigned | — |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per SYR